No hu­mans al­lowed: Alex Zha­voronkov adds ro­bot­ic lab to his AI drug dis­cov­ery play as In­sil­i­co un­veils $60M raise

For Alex Zha­voronkov, the re­cent biotech mar­ket down­turn is, in fact, a good thing.

The In­sil­i­co CEO — in his sig­na­ture con­fi­dent ex­u­ber­ance — said the cri­sis is wash­ing out the “tiny play­ers” in the ar­ti­fi­cial in­tel­li­gence space that can’t stand the tri­al by fire. Be­sides, un­der such volatile con­di­tions, the $60 mil­lion Se­ries D he just raised makes for a “hero­ic tes­ta­ment” to the progress his com­pa­ny has made.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER